The symposium is chaired by Jawed Fareed, Ph.D., Professor of Pathology and Pharmacology, Director of Hemostasis and Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, Illinois, USA. The symposium will include presentations from leading experts regarding emerging topics in anticoagulation management as well as for patients at risk of thrombosis and related disorders.
The distinguished faculty representing leading international institutions will present and discuss new treatment modalities for the prevention and treatment of patients at risk for thrombotic and vascular disorders including atrial fibrillation, acute coronary syndromes, diabetes, cancer and transplantation associated veno-occlusive disorder. In addition, experts will consider recent worldwide regulatory developments that are changing the landscape of anticoagulation therapy which include the introduction of newer oral anticoagulants and generic versions of branded drugs.
About Pharmaceutical Strategic Initiatives:
Pharmaceutical Strategic Initiatives, LLC (PSI) is the premier provider of strategic clinical and regulatory consulting, priority comparative effectiveness and outcomes research, scientific content creation, opinion leader development and management to Academic Institutions, Pharmaceutical, Medical Device and Biotechnology companies. For 26 years, PSI has supported Educational Programs and Workshops, Medical Affairs, Regulatory Affairs, and Medical Marketing teams by developing successful business strategies and providing the implementation skills required to produce clear, measurable outcomes. Charles A. Carter, Pharm.D., MBA is president of Pharmaceutical Strategic Initiatives, LLC. PSI's offices are in Research Triangle Park, North Carolina. For more information about PSI, contact Mary Messina at 919.314.1380 or visit www.psillc.com.
SOURCE Pharmaceutical Strategic Initiatives, LLC
